Korea Investment Corp’s CureVac CVAC Stock Holding History

Korea Investment Corp’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50,700	Closed	-$3.73M	–	735
2021 Q2	$3.73M	Buy	+50,700	New	+$5.07M	0.01%	592

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

Korea Investment Corp's CVAC Position: Q3 2021 in Review

Korea Investment Corp sold out of CureVac (CVAC) in Q3 2021, closing a stake of 50,700 shares — an estimated $3.73M sold.

Korea Investment Corp first reported a position in CVAC in Q2 2021 and held it in 1 quarter. The position peaked at $3.73M in Q2 2021. 111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

Korea Investment Corp reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
Korea Investment Corp sold 50,700 CureVac shares in Q3 2021, an estimated $3.73M.
Korea Investment Corp first reported a position in CureVac in Q2 2021 and held it in 1 quarter.
Korea Investment Corp's CureVac position peaked at $3.73M in Q2 2021.
111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on Korea Investment Corp's 13F filing for Q3 2021, filed 12 Nov 2021.